Soligenix

315 articles with Soligenix

• Soligenix Announces Appointment of Jerome Zeldis, MD, PhD and Keith Brownlie, CPA to its Board of Directors

  6/27/2011

• Soligenix Appoints Joseph Warusz as Vice President of Administration and Controller

  6/2/2011

• Soligenix Reports First Quarter 2011 Financial Results and Reviews Accomplishments

  5/13/2011

• Soligenix Reports Year-End 2010 Financial Results and Highlights Recent Accomplishments

  3/29/2011

• Soligenix to Present at 13th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference

  2/9/2011

• Soligenix Appoints Kevin Horgan, MD, as Chief Medical Officer

  2/1/2011

• Soligenix Executes Exclusive License with the University of Colorado for Vaccine Thermostabilization Technology

  1/27/2011

• Soligenix Receives $245,810 in Non-Dilutive Financing from New Jersey's Technology Business Tax Certificate Transfer Program

  1/25/2011

• Soligenix Receives FDA Orphan Drug Designation for RiVax(TM) for the Prevention of Ricin Intoxication

  1/20/2011

• Soligenix Announces Positive Preliminary Results of SGX202 in Radiation Injury

  1/18/2011

• Soligenix Announces Issuance of United States Patent for RiVax(TM), its Vaccine Against Ricin Toxin

  11/22/2010

• Soligenix Reports Third Quarter 2010 Financial Results and Reviews Accomplishments

  11/12/2010

• Soligenix Receives Award Totaling $244,479 for orBec(R) Program From Qualifying Therapeutic Discovery Project

  11/3/2010

• Soligenix Announces Completion of Enrollment and Preliminary Safety Results of a Phase 1B Clinical Trial for RiVax(TM)

  11/2/2010

• Soligenix Announces Preliminary Results of its Phase 2 Clinical Trial of orBec(R) in the Prevention of Acute GVHD

  10/25/2010

• Soligenix Provides Corporate Update on Phase 3 Trials

  9/27/2010

• Soligenix Announces Award of $1.2 Million FDA Orphan Products Development Grant

  8/23/2010

• Soligenix Reports Second Quarter 2010 Financial Results and Reviews Accomplishments

  8/13/2010

• Soligenix to Present at the OneMedForum Conference on Wednesday, June 30 at 2PM EDT

  6/29/2010

• Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax(TM) Administration

  6/25/2010